You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › February › 04
Ozempic
4 months ago
The maker of Ozempic and Wegovy is predicting a sharp decline in sales this year as it grapples with more effective competitors and new policies from the president.
Wegovy and Ozempic maker forecasts sharp drop in revenue for 2026 ⊖
found
a story from The Guardian ⚠️ › International
Novo Nordisk share price plunges after blaming lower US drug prices, patent protection issues and rising competition
The maker of Wegovy and Ozempic, Novo Nordisk, has predicted a sharp drop in reven…
page 1 of 1